| Consolidated & Uncosolidated Financial Highlight |
| Item |
FY2008
(March 31, 2009) |
FY2009
(March 31, 2010) |
FY2010
(March 31, 2011) |
| Unconsolidated |
Consolidated |
Unconsolidated |
Consolidated |
Unconsolidated |
Consolidated |
| Financial results |
Net sales(mil, ) |
17,996 |
22,435 |
13,333 |
17,886 |
15,429 |
20,171 |
Operating income(mil, ) |
1,687 |
2,016 |
700 |
896 |
1,685 |
2,144 |
Ordinary income(mil, ) |
1,869 |
2,029 |
889 |
1103 |
1,906 |
2,325 |
Selling, general & administrative
expenses(mil, ) |
4,617 |
6,783 |
3,852 |
6,006 |
4,149 |
6,312 |
Net income(mil, ) |
1,042 |
1,376 |
615 |
711 |
983 |
1,379 |
Net income per share( ) |
22.59 |
29.84 |
13.37 |
15.44 |
21.78 |
30.53 |
| Financial position |
Total assets(mil, ) |
22,149 |
23,482 |
22,495 |
24,140 |
23,013 |
24,468 |
Net assets(mil, ) |
16,538 |
16,821 |
16,824 |
17,440 |
16,794 |
17,367 |
| Ratio of shareholders' equity(%) |
74.7 |
69.2 |
74.8 |
69.4 |
73.0 |
38.7 |
Net assets per share( ) |
358.49 |
352.38 |
370.59 |
368.81 |
378.70 |
378.87 |
| ROA(%) |
4.4 |
5.5 |
2.8 |
3.0 |
4.3 |
5.7 |
| ROE(%) |
6.3 |
8.4 |
3.7 |
4.3 |
5.9 |
8.2 |
| Cash flows |
Cash flows from operating activities(mil, ) |
- |
1,670 |
- |
1,778 |
- |
2,620 |
Cash flows from investing activities(mil, ) |
- |
 154 |
- |
 2,081 |
- |
 916 |
Cash flows from financing activities(mil, ) |
- |
 710 |
- |
 438 |
- |
 1,072 |
Cash and cash equivalents at the
end of period(mil, ) |
- |
5,210 |
- |
4,507 |
- |
5,039 |
|
 |
| Consolidated Financial Highlight of
FY2011 |
 |
FY2011 |
|
| Item |
1Q |
2Q |
3Q |
| April 1 through June 30 |
April 1 through September 30 |
April 1 through December 31 |
| Consolidated financial
results |
Net sales(mil, ) |
4,990 |
10,747 |
|
Operating income(mil, ) |
357 |
1,084 |
|
Ordinary income(mil, ) |
470 |
1,176 |
|
Net income(mil, ) |
275 |
722 |
|
Net income per share( ) |
6.21 |
16.36 |
|
| Consolidated financial
position |
Total assets(mil, ) |
24,368 |
24,858 |
|
Net assets(mil, ) |
17,585 |
17,685 |
|
| Ratio of shareholders' equity(%) |
69.8 |
69 |
|
Net assets per share( ) |
383.7 |
392.7 |
|
| Consolidated cash flows |
Cash flows from operating activities(mil, ) |
- |
649 |
|
Cash flows from investing activities(mil, ) |
- |
57 |
|
Cash flows from financing activities(mil, ) |
- |
 494 |
|
Cash and cash equivalents at the
end of period(mil, ) |
- |
5,270 |
|
|
 |
Net sales |
|
 |
Ordinary income/Ordinary income ratio |
|
 |
Unconsolidated |
 |
Consolidated |
 |
|
 |
 |
 |
Unconsolidated |
 |
 |
Consolidated |
 |
|
|
|
 |
|
 |
Net income/Net income ratio |
|
 |
Selling, general & administrative expenses |
|
 |
Unconsolidated |
 |
Consolidated |
 |
|
 |
 |
 |
Unconsolidated |
 |
 |
Consolidated |
 |
|
|
|
 |
|
 |
Ratio of shareholders' equity(Unconsolidated) |
|
 |
Ratio of shareholders' equity(Consolidated) |
|
 |
 |
Unconsolidated |
 |
 |
Gross capital |
 |
|
 |
 |
 |
Consolidated |
 |
 |
Gross capital |
 |
|
|
|
 |
|
 |
Net income per share |
|
 |
Net assets per share |
|
 |
Unconsolidated |
 |
Consolidated |
 |
|
 |
 |
Unconsolidated |
 |
Consolidated |
 |
|
|
|
 |
|
 |
ROA |
|
 |
ROE |
|
 |
Unconsolidated |
 |
Consolidated |
 |
|
 |
 |
Unconsolidated |
 |
Consolidated |
 |
|
|
|
 |
|
|
|
|